ZNF473 as a biomarker and potential therapeutic target in cancer: integrated bioinformatics and experimental evidence with a focus on hepatocellular carcinoma

Yifan Ren, Tongxiang Wang, Yuqing Sun, Rui Zhang, Yan Wang, Jun Xu · 2026

Read ZNF473 as a biomarker and potential therapeutic target in cancer: integrated bioinformatics and experimental evidence with a focus on hepatocellular carcinoma by Yifan Ren, Tongxiang Wang, Yuqing Sun, Rui Zhang, Yan Wang, Jun Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13218875.txt.

Description

Yifan Ren and co-authors study a zinc finger protein, ZNF473, as a possible marker and drug target across cancers, with a focus on liver cancer. Published in 2026, the work joins large scale data analysis with cell and animal tests. The protein's exact roles are still unclear, though it has been linked to regulation in several cancer types.

The protein was turned up in more than ten cancer types, and its levels tracked molecular and immune subtypes. As a diagnostic sign it performed moderately in nineteen cancer types. Survival links appeared in four cancers, most consistently in liver cancer, where high levels went with worse clinical traits. The authors present the gene as a candidate biomarker worth further study.

Catalog record

CREATORYifan Ren, Tongxiang Wang, Yuqing Sun, Rui Zhang, Yan Wang, Jun Xu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13218875

Browse the full library · About the Tower of Babel